Page last updated: 2024-11-04

terfenadine and Fatty Liver

terfenadine has been researched along with Fatty Liver in 1 studies

Terfenadine: A selective histamine H1-receptor antagonist devoid of central nervous system depressant activity. The drug was used for ALLERGY but withdrawn due to causing LONG QT SYNDROME.

Fatty Liver: Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Raveendran, VV1
Kassel, KM1
Smith, DD1
Luyendyk, JP1
Williams, KJ1
Cherian, R1
Reed, GA1
Flynn, CA1
Csanaky, IL1
Lickteig, AL1
Pratt-Hyatt, MJ1
Klaassen, CD1
Dileepan, KN1

Other Studies

1 other study available for terfenadine and Fatty Liver

ArticleYear
H1-antihistamines exacerbate high-fat diet-induced hepatic steatosis in wild-type but not in apolipoprotein E knockout mice.
    American journal of physiology. Gastrointestinal and liver physiology, 2014, Jul-15, Volume: 307, Issue:2

    Topics: Animals; Apolipoproteins E; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Ca

2014